tetradecanoylphorbol acetate and rocaglamide

tetradecanoylphorbol acetate has been researched along with rocaglamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumann, B; Bohnenstengel, F; Debatin, KM; Herr, I; Proksch, P; Siegmund, D; Wajant, H; Weber, C; Wirth, T	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and rocaglamide

Article	Year
Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. The Journal of biological chemistry, 2002, Nov-22, Volume: 277, Issue:47 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzofurans; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Humans; I-kappa B Kinase; I-kappa B Proteins; Leukemia, T-Cell; Mice; Molecular Structure; NF-kappa B; NF-KappaB Inhibitor alpha; Protein Serine-Threonine Kinases; Rats; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	2002

Article

Year

Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.

The Journal of biological chemistry, 2002, Nov-22, Volume: 277, Issue:47

Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzofurans; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Humans; I-kappa B Kinase; I-kappa B Proteins; Leukemia, T-Cell; Mice; Molecular Structure; NF-kappa B; NF-KappaB Inhibitor alpha; Protein Serine-Threonine Kinases; Rats; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2002